Search

Dr. Jane Foster, a leading expert in microbiota-immune biomarkers in neuroscience and psychiatry, was recruited and joined the Center for Depression Research and Clinical Care (CDRC) in May 2022. Dr. Foster’s molecular biology laboratory expands the current clinical research lab to include state-of-the-art equipment for genomic (DNA, RNA) and proteomic analysis of clinical biospecimens and tissue samples collected from mouse models. Dr. Foster also leads reverse translational work in mice to identify molecular mechanisms that connect the microbiome and the immune system to the brain.

The Moreland and Potera Labs utilize basic science approaches, in vivo models, and clinical studies to investigate cellular functions of the innate immune system.

Skip to main content People Current Lab Members Claudia Saborit, M.D. Resident in Internal Medicine Email Changlin Gong. M.D. Visiting Student Hemanth Karnati, B.S. Research Technician Email Xin Long Visiting Reseacher Email Lab Alumni Name Lab Role Current Role Beishi Zheng, M.D., 2019-2022 Internal…

The Orth lab is interested in elucidation the activity of virulence factors from pathogenic bacteria so that we can gain novel molecular insight into eukaryotic signaling systems.

We are interested in understanding the deregulation of epigenetic and transcriptional pathways in human disease and in finding small molecules with therapeutic potential to normalize these gene expression patterns. 

Check out open positions in Jamieson Lab! We work with clinicians and basic research scientists on diverse projects. 

For decades, the field of tuberculosis (TB) immunology has focused on T cell mediated protection, yet Mycobacterium tuberculosis (Mtb) still impacts one in four individuals worldwide today.

Meet the members of the CMRU Cardiomatabolic Research Unit

The Schoggins Lab studies innate immunity at the virus-host interface. We are interested in mechanisms of cellular antiviral defense and the role these responses play during viral disease.

Current projects include JAK-STAT and celiac disease and Targeting Dendritic Cells for the treatment of Inflammatory Bowel Disease